Home
About
Publications Trends
Recent Publications
Expert Search
Archive
pahs (polycyclic aromatic hydrocarbons)
How Are Humans Exposed to PAHs?
Humans can be exposed to PAHs through various routes including inhalation, ingestion, and dermal contact. Common sources of exposure include:
Cigarette smoke
Vehicle exhaust
Grilled and charred foods
Industrial emissions
Residential wood burning
Frequently asked queries:
What are Polycyclic Aromatic Hydrocarbons (PAHs)?
How Are Humans Exposed to PAHs?
How Do PAHs Cause Cancer?
Which Types of Cancer Are Associated with PAH Exposure?
What Are the Mechanisms of PAH-Induced Carcinogenesis?
What Are the Regulatory Guidelines for PAHs?
How Can PAH Exposure Be Reduced?
How Often Should Cancer Patients Engage in Bodyweight Exercises?
How Can Sleep Disturbances be Managed in Cancer Patients?
Is Amitriptyline Suitable for All Cancer Patients?
How are Cancer Metrics Collected?
Can Autoimmune Disorders Be a Result of Cancer Treatment?
How Do Environmental Factors Influence Cancer Risk?
What is the Future of Fusion Gene Detection?
How Can Patients Improve Their Digital Literacy?
What Are International Patient Services?
What Are the Alternatives to Wigs?
How to Choose the Right Fellowship Program?
How is Uniformity Measured?
What questions should you ask during your consultation?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe